All Pharmacology Flashcards
(124 cards)
Explain the mechanism of action of Atropine
Atropoine is a muscarinic receptor antagonist.
Atropine binds to and inhibits the muscarinic acetylcholine receptor. Adequate doses of atropine abolish various types of reflex vagal cardic slowing or asystole.
The drug also prevents or abolishes bradycardia or asystole produced by injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus.
Atropine may lessen the degree of partial heart block when vagal activity is an etiological factor.
Explain the mechanism of action of Betamethasone.
Betamethasone is a glucocorticoid receptor agonist. Binding of betamethasone to the glucocorticoid receptor forms a complex which moves to the nucleus, binds DNA causing alteration in gene transcription.
This altered gene transcription causes the production of lipocortins, which inhibits transcription. This altered gene transcription causes the production of lipocortins, which inhibits phospholipase A2 and therefore reduces the biosynthesis of prostaglandins and leukotrienes.
In addition, corticoid steroid reduces the gene expression of interleuken-1, which is an important inflammatory cytokine.
The overall effect of both action drives the anti-inflammatory immunosupressive and anti-mitogenic effects of steroids.
In the plasmna, it binds to transcortin, and it becomes active when it is not bound to transcortin.
If prescribed to be taken orally it is best to use in combination with beclomethasone. If prescribed as a glucocorticoid, then better with hydrocortisone or prednisolone.
Explain the mechanism of action of Digoxin
Digoxin is a cardiac glycoside (A sodium potassium ATPase inhibitor).
Digoxin is used to treat congestive heart failure, and supraventricular arrythmias.
It’s mode of action is via inhibition of the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium.
This causes in turn the sodium calcium exchanger (NCX) to extrude the sodium and pump in more calcium.
This alteration in calcium concentration is thought to promote activation of contractile proteins (e.g. actin, myosin). Digoxin also acts on the electrical activity of the heart, increasing the slope of phase 4 depolarisation, shorterning the action potential duration, and decreasing the maximal diastolic potential.
Explain the mechanism of action of Edrophonium
Edrophonium is a rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis.
Edrophonium’s mode of action is to prolong the action of acetylcholine, via inhibiting acetylcholinesterase at sites of cholinergic transmission. Its effect is present within 60 seconds after injection and lasts for an average of 10 minutes.
Nicotinic acetylcholine receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes muscle contraction.
In myasthenia gravis the body’s immune system destroys many of the nicotinic acetylcholine receptors, so the muscle is less responsive to nervous stimulation.
Edrophonium increases the amount of acetylcholine at the nerve endings, therefore allowing the remaining receptors to function more efficiently.
Still used as part of tensilon test. Otherwise more likely to be used: pyridostigmine.
Explain the mechanism of action of Ethanol.
Ethanol has multiple effects. It
1) Binds to receptors for acetylcholine, serotonin, GABA and NMDA receptors. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning.
2) Ethanol has an anti-infective role as it acts as a dehydrating agent that disrupts osmotic balance across cell membranes.
Fomepizole has replaced first line treatment for methanol/ethylene glycol poisoning.
Explain the mechanism of action of Ethinylestradiol.
Ethinylestradiol is a synthetic derivative of natural estrogen testradiol.
It interacts with estrogen receptor (alpha or beta) present on female organs, breasts, the hypothalamus and pituitary gland.
Upon ligand binding, the estrogen receptor enters the nucleus and regulates gene transcription. This leads to an increase in the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid binding globulin (TBG) and other seum proteins, and suppresses FSH from the anterior pituitary.
During mensturation, increasing oestradiol levels causes the maturation and release of the egg; as well as thickening of the uterus lining to allow a fertilised egg to implant.
The hormone is made primarily in the ovaries, so levels reduce as women age and decrease significantly during menopause. Too much oestradiol has been linked to acne, constipation, loss of sex drive and depression. Conversely, too little oestradiol retards bone growth and development.
In men, proper oestradiol levels help with bone maintenance, nitric oxide production and brain function. Used within the combined oral contraceptive pill.
Explain the mechanism of action of Ketaconazole.
Ketaconazole is a broad-spectrum anti-fungal agent (A Lanosine demethylase inhibitor). It inhibits 14-alpha-demethylase, a cytochrome p450 enzyme which converts lanosterol to ergosterol.
The inhibition of ergosterol causes increased fungal cellular permeability. However, there are also other possible mechanisms of its action.
1) Inhibition of endogenous respiration.
2) Interaction with membrane phospholipids.
3) Inhibition of yeast transformation to mycelial forms.
4) Inhibition of purine uptake.
5) Impairment of triglycerice and/or phospholipid biosynthesis.
Explain the mechanism of action of Morphine.
Morphine is an analgesic (an opiate agonist).
The precise mechanism is unknown. However, it binds to certain other receptors including:
1) The mu-opiod receptors. The mechanism of respiratory depression involves a reduction in the brain stem respiratory centres to increases in carbon dioxide tension and electrical stimulation.
2) The GABA inhibitory interneurons. Morphine inhibits the activity of these and therefore limits the descending pain inhibition pathway. Therefore, without the inhibitory signals, pain modulation can proceed downstream.
Explain the mechanism of action of Naloxone.
Naloxone is an opiate antagonist that prevents or reverses the effects of opioids such as respiratory depression, sedation and hypotension. As such it is described as a pure narcotic antagonist (and therefore does not induce respiratory depression).
Its mechanism of action is not clear but it is though to be able to antagonise all three opioid receptors (Mu, Kappa, and Gamma), although it has the strongest binding to the Mu receptor. It onset of action is dependent on how it is given but intravenously, the onset of action is within 2 minutes, whilst its effects are slower if given subcutaneously or intramuscularly’
Naloxone can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine.
Explain the mechanism of action of Rifampicin
Rifampicin is a broad spectrum antibiotic (targets both gram positive and gram negative bacteria). It is easily absorbed and distributed throughout the body.
Its mode of action is via the inhibition of DNA-dependent RNA polymerase, leading to a supression of RNA synthesis and cell death.
Importantly, Rifampicin can target bacterial but not mammalian versions of the enzyme. Due to the emergence of resistant bacteria, the use of Rifampicin is restricted to Tuberculosis.
Rifampicin is metabolised in the liver and eliminated mainly in the bile, and, to a limited extent, in urine.
Explain the mechanism of action of Suxamethonium
Suxamethonium’s mode of action is to mimic acetylcholine at the neuromuscular junction. However, Suxamethonium is hydrolysed much slower than acetylcholine, causing prolonged depolarisation and therefore desensitisation and muscle relaxation.
Unlike the non-depolarising neuromuscular blocking drugs, Suxamethonium cannot be reversed and recovery is spontaneous.
Suxamethonium is given after a general anaesthetic as muscle relaxation can be preceded by painful muscular fasciculations.
Anticholinesterases such as neostigmine is given alongside Suxamethonium to potentiate the neuromuscular block.
Explain the mechanism of action of Tamoxifen
Tamoxifen is a selective estrogen receptor modulator (SERM).
It can have both estogenic and antiestrogenic effects.
The mode of action of Tamoxifen is via binding to the estrogen receptor, leading to a conformational change in the receptor and therefore altering the expression of estrogen dependent genes.
Prolonged binding of Tamoxifen to the nuclear chromatin reduces DNA polymerase activity, impairs thymidine utilization, blocks estradiol uptake, and decreases estrogen response. Tamoxifen can bind either the ER-a or Erb receptors, and most likely will interact with multiple co-repressors, or co-activators leading to its ability to have either estrogenic or antiestrogenic effects.
Explain the mechanism of action of Tubocurarine.
Tubocurarine binds stereo-selectively to nicotinic-cholinergic receptors at the autonomic ganglia, the adrenal medulla, neuromuscular junctions, and in the brain.
Tubocurarine has two main effects: stimulation and reward.
Te stimulatory effect occurs mainly in the cortex via the locus cerulus, whilst the reward effect is exerted in the limbic system. At low doses, the stimulant effects predominate whilst at higher doses the reward effects predominate.
Tubocurarine has been superceded by Suxamethonium as the clinically used depolarising neuromuscular blocker.
Explain the mechanism of action of Paracetemol
Paracetemol is an analgesic and antipyretic compound (a COX inhibitor).
Paracetamol is used when NSAIDs cannot be. An example is a patient with peptic ulcer. It has analgesic and antipyretic effects, but lacks ant platelet, anti-inflammatory, and gastric ulcerative effects. The mechanism of action is complex and not well understood. There are three possible mechanisms
1) It indirectly inhibits COX, which is ineffective in the presence of peroxides. This could explain why it does not work well within platelets.
2) It inhibits COX-3. This enzyme is not well understood.
3) Its antipyretic effects are due to effects on the hypothalamus, resulting in peripheral vasodilation and sweating.
Explain the mechanism of action of Diamorphine (Heroin)
Diamorphine/Heroin is an opiate receptor agonist (analgesic).
Heroin is a mu-opioid agonist. Heroin, targets four endogenous neurotransmitters (beta-endorphin, dynorphin, leu-enkephalin, and met-enkephalin). Heroin reduces (and sometimes stops) production of the endogenous opioids. Endorphins are regularly released in the brain and nerves, attenuating pain.
The onset of heroin’s effects is dependent on the method of administration. Taken orally, heroin is totally metabolized in vivo into morphine before crossing the blood-brain barrier; so the effects are the same as oral morphine. Taken by injection, heroin crosses into the brain, where it is rapidly metabolized into morphine by removal of the acetyl groups. It is the morphine molecule that then binds with opioid receptors and produces the subjective effects of the heroin high.
Still used clinically, but probably morphine more common in clinical practice.
Explain the use of oxygen in clinical settings.
Oxygen levels, or oxygen saturation is a key clinical diagnostic. Healthy individuals should have an Oxygen SAT of greater than 96%. However, patients with lung diseases, such as pneumonia, can have reduced ability to breathe in or transport oxygen effectively, identified in a reduced Oxygen SAT (less than 88%). Therefore, patients with low blood oxygen levels can be treated with additional pure oxygen or air/oxygen mixtures via a mask, nasal cannula, or tracheal intubation. This increased delivery of oxygen should alleviate the symptoms caused by low oxygen levels in the tissues.
What are B-Adrenergic antagonists?
(Atenolol, Propanolol etc).
b-adrenergic antagonists competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart and vascular smooth muscle. This results in a reduction in resting heart rate, cardiac output, systolic and diastolic blood pressure, and reflex orthostatic hypotension.
Explain the mechanism of action of Atenolol
Atenolol has similar properties to propranolol, but does not have a negative inotropic effect. Higher doses of Atenolol also competitively block beta(2)-adrenergic responses in the bronchial and vascular smooth muscles.
Atenolol is not commonly used today, much more likely to be bisoprolol.
Explain the mechanism of action of Propanolol
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol is used in the treatment or prevention of many disorders including acute myocardial infarction, arrhythmias, angina pectoris, hypertension, hypertensive emergencies, hyperthyroidism, migraine, pheochromocytoma, menopause, and anxiety.
Rarely used other than in migraine, cirrhosis of the liver with portal hypertension, and in thyrotoxicosis
Explain the use of Bendroflumethiazide.
Bendroflumethiazide is a thiazide diuretic.
Bendroflumethiazide, as a diuretic increases urinary excretion of water, and can cause blood vessel dilatation. It has two mechanisms of action,
1) It inhibits the Na-Cl cotransporter, blocking active chloride reabsorption in the early distal tubule. This results in an increase in the excretion of sodium, chloride, and water.
2) It inhibits sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism.
Both of these mechanism apply to its role as a diuretic. However its antihypertensive mechanism is less well understood. It may act although it may be mediated
1) inhibiting carbonic anhydrases in the smooth muscle
2) activating the large-conductance calcium-activated potassium (KCa) channel, in the smooth muscle.
Explain the mechanism of action of Digoxin.
Digoxin is a cardiac glycoside (a sodium postassium ATPase inhibitor)
Digoxin is used to treat congestive heart failure, and supraventricular arrhythmias. Its mode of action is via inhibition of the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium. This causes in turn the sodium calcium exchanger (NCX) to extrude the sodium and pump in more calcium. This alteration in calcium concentration is thought to promote activation of contractile proteins (e.g., actin, myosin). Digoxin also acts on the electrical activity of the heart, increasing the slope of phase 4 depolarization, shortening the action potential duration, and decreasing the maximal diastolic potential.
Still used in Atrial Fibrillation, but now very much third line treatment option. Rarely used in heart failure as much better drugs available
Explain the mechanism of action of Amiodarone.
Amiodarone is an antianginal and antirhythmic agent.
Amiodarone is a Vaughan-Williams Class III antiarrhythmic agent. The antiarrhythmic effect of amiodarone may be due to at least two major actions.
1) Prolonging the myocardial cell-action potential (phase 3) duration and refractory period and
2) Acts as a noncompetitive a- and b-adrenergic inhibitor.
It can also have
1) b-blocker activity and calcium channel blocker-like actions on the SA and AV nodes
2) increases the refractory period via sodium- and potassium-channel effects
3) slows intra-cardiac conduction of the cardiac action potential, via sodium-channel effects.
Still used but much less common as defibrillators are now inserted.
Explain the mechanism of action of Warfarin.
Warfarin is an anticoagulant (a Vitamin K antagonist).
Warfarin is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF). Warfarin can cross the placental barrier during pregnancy resulting in foetal bleeding, spontaneous abortion, and neonatal death.
Warfarin inhibits vitamin K reductase, reducing levels of the reduced form of vitamin K. As vitamin K is required for the production of coagulation factors II, VII, IX, and X and anticoagulant proteins C and S, these levels also drop. Depression of three of the four vitamin K-dependent coagulation factors (factors II, VII, and X) results in decreased prothrombin levels, decreased thrombin generation and reduced ability to form a clot.
Warfarin is declining in use with the advent of non-vitamin K antagonist oral anticoagulants.
Explain the mechanism of action of Ramipril, Lisinopril, Enalapril and Captopril.
They are competative inhibitors of angiotensin converting enzyme (ACE).
ACE converts angiotensin I to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). ATII increases blood pressure using a number of mechanisms.
1)Stimulation of secretion of aldosterone from the adrenal cortex
2)Stimulation of Vasopression secretion from the posterior pituitary gland.
3)Through direct arterial vasoconstriction.
In addition ATII induces the thirst response via stimulation of hypothalamic neurons. There are two isoforms of ACE, a somatic isoform, and a testicular isoform. Somatic ACE has two functionally active domains, N and C. The C-domain is predominantly involved in blood pressure regulation while the N-domain plays a role in hematopoietic stem cell differentiation and proliferation. ACE inhibitors bind to and inhibit the activity of both domains, but have much greater affinity for and inhibitory activity against the C-domain.
Captopril inhibits the conversion of ATI to ATII and therefore inhibits increases in blood pressure. Captopril’s affinity for ACE is approximately 30,000 times greater than that of ATI. ACE is also involved in the deactivation of bradykinin. Inhibiting the deactivation of bradykinin increases bradykinin levels causing increased vasodilation and decreased blood pressure.
Ramipril is the drug of choice, followed by Lisinopril, and rarely Enalapril. Captopril is hardly prescribed.
